AI company Anthropic has launched Claude Science, a new platform designed to help scientists conduct research, analyse biological data and manage complex scientific workflows. The company says the product is intended to do for scientific research what its coding assistant, Claude Code, does for software engineering.

The platform combines coding tools, compute resources and access to more than 60 scientific databases in a single environment. It is pre-configured for fields such as genomics, proteomics, structural biology and drug discovery, and includes AI agents that can assist with research tasks and review calculations and citations.

Claude Science can also render scientific data, including protein structures and chemical models, while providing the code and workflow behind generated results to improve reproducibility.

Who Can Use It

Claude Science is available in beta to all Claude Pro, Max, Team, and Enterprise subscribers. Anthropic is also supporting up to 50 Claude Science AI for Science projects, providing up to $30,000 in credits per project, with applications open through July 15, 2026.

Anthropic Is Also Doing Its Own Drug Research

In a move that goes well beyond tooling, Anthropic also announced it is launching its own pre-clinical drug programs focused on neglected diseases, areas outside the scope of what traditional pharma and biotech typically consider commercially attractive, but which carry significant global health burden.

Claude Science also places Anthropic in direct competition with science-focused AI offerings from OpenAI and Google DeepMind, signalling the growing race to apply artificial intelligence to scientific research and drug discovery.